MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)

• Status: Completed
• Trial end date: 2009-04-27
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the efficacy and safety of an investigational treatment for type 2 diabetes mellitus.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Metformin; Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• Patient has type 2 diabetes mellitus

• Patient is greater than or equal to 18 and less than or equal to 78 years of age on the day of signing the consent

• Patient has Hb1Ac greater than or equal to 7.5% and is appropriate for oral therapy

• Patient has not been on any antihyperglycemic agent (AHA) in the last 4 months

• Patient is a male, or a female who is unlikely to conceive

Exclusion Criteria:

• Patient has type 1 diabetes mellitus or history of ketoacidosis